United States Opioids Drug Market Report 2018

Name: United States Opioids Drug Market Report 2018
Brand: QYResearch
SKU: U44CE9E57E4EN
Price: 3800 USD
Availability: InStock

February 2018 | 108 pages | ID: U44CE9E57E4EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Opioids Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Opioids Drug in these regions, from 2013 to 2025 (forecast).

United States Opioids Drug market competition by top manufacturers/players, with Opioids Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Generic
Branded

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospitals
Clinics
Drugstores

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Opioids Drug Market Report 2018

1 OPIOIDS DRUG OVERVIEW

1.1 Product Overview and Scope of Opioids Drug
1.2 Classification of Opioids Drug by Product Category
  1.2.1 United States Opioids Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Opioids Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Generic
  1.2.4 Branded
1.3 United States Opioids Drug Market by Application/End Users
  1.3.1 United States Opioids Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Drugstores
1.4 United States Opioids Drug Market by Region
  1.4.1 United States Opioids Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Opioids Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Opioids Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Opioids Drug Status and Prospect (2013-2025)
  1.4.5 New England Opioids Drug Status and Prospect (2013-2025)
  1.4.6 The South Opioids Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Opioids Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Opioids Drug (2013-2025)
  1.5.1 United States Opioids Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Opioids Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES OPIOIDS DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Opioids Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Opioids Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Opioids Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Opioids Drug Market Competitive Situation and Trends
  2.4.1 United States Opioids Drug Market Concentration Rate
  2.4.2 United States Opioids Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Opioids Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OPIOIDS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Opioids Drug Sales and Market Share by Region (2013-2018)
3.2 United States Opioids Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Opioids Drug Price by Region (2013-2018)

4 UNITED STATES OPIOIDS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Opioids Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Opioids Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Opioids Drug Price by Type (2013-2018)
4.4 United States Opioids Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES OPIOIDS DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Opioids Drug Sales and Market Share by Application (2013-2018)
5.2 United States Opioids Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES OPIOIDS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Opioids Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.2 Opioids Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Opioids Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Grunenthal
  6.3.2 Opioids Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Grunenthal Opioids Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Bayer
  6.4.2 Opioids Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bayer Opioids Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Opioids Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Opioids Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Eli Lilly
  6.6.2 Opioids Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Eli Lilly Opioids Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 AstraZeneca
  6.7.2 Opioids Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AstraZeneca Opioids Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Endo
  6.8.2 Opioids Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Merck
  6.9.2 Opioids Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Merck Opioids Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Depomed
  6.10.2 Opioids Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Depomed Opioids Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Yunnan Baiyao
6.12 Teva
6.13 J&J
6.14 Allergan
6.15 Purdue

7 OPIOIDS DRUG MANUFACTURING COST ANALYSIS

7.1 Opioids Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Opioids Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Opioids Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Opioids Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OPIOIDS DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Opioids Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Opioids Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Opioids Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Opioids Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Opioids Drug
Figure United States Opioids Drug Market Size (K Units) by Type (2013-2025)
Figure United States Opioids Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Generic Product Picture
Figure Branded Product Picture
Figure United States Opioids Drug Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Opioids Drug by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Drugstores Examples
Table Key Downstream Customer in Drugstores
Figure United States Opioids Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Opioids Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Opioids Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Opioids Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Opioids Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Opioids Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Opioids Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Opioids Drug Sales (K Units) and Growth Rate (2013-2025)
Figure United States Opioids Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Opioids Drug Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Opioids Drug Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Opioids Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Opioids Drug Sales Share by Players/Suppliers
Figure 2017 United States Opioids Drug Sales Share by Players/Suppliers
Figure United States Opioids Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Opioids Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Opioids Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Opioids Drug Revenue Share by Players/Suppliers
Figure 2017 United States Opioids Drug Revenue Share by Players/Suppliers
Table United States Market Opioids Drug Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Opioids Drug Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Opioids Drug Market Share of Top 3 Players/Suppliers
Figure United States Opioids Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Opioids Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Opioids Drug Product Category
Table United States Opioids Drug Sales (K Units) by Region (2013-2018)
Table United States Opioids Drug Sales Share by Region (2013-2018)
Figure United States Opioids Drug Sales Share by Region (2013-2018)
Figure United States Opioids Drug Sales Market Share by Region in 2017
Table United States Opioids Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Opioids Drug Revenue Share by Region (2013-2018)
Figure United States Opioids Drug Revenue Market Share by Region (2013-2018)
Figure United States Opioids Drug Revenue Market Share by Region in 2017
Table United States Opioids Drug Price (USD/Unit) by Region (2013-2018)
Table United States Opioids Drug Sales (K Units) by Type (2013-2018)
Table United States Opioids Drug Sales Share by Type (2013-2018)
Figure United States Opioids Drug Sales Share by Type (2013-2018)
Figure United States Opioids Drug Sales Market Share by Type in 2017
Table United States Opioids Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Opioids Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Opioids Drug by Type (2013-2018)
Figure Revenue Market Share of Opioids Drug by Type in 2017
Table United States Opioids Drug Price (USD/Unit) by Types (2013-2018)
Figure United States Opioids Drug Sales Growth Rate by Type (2013-2018)
Table United States Opioids Drug Sales (K Units) by Application (2013-2018)
Table United States Opioids Drug Sales Market Share by Application (2013-2018)
Figure United States Opioids Drug Sales Market Share by Application (2013-2018)
Figure United States Opioids Drug Sales Market Share by Application in 2017
Table United States Opioids Drug Sales Growth Rate by Application (2013-2018)
Figure United States Opioids Drug Sales Growth Rate by Application (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Opioids Drug Sales Growth Rate (2013-2018)
Figure Pfizer Opioids Drug Sales Market Share in United States (2013-2018)
Figure Pfizer Opioids Drug Revenue Market Share in United States (2013-2018)
Table GSK Basic Information List
Table GSK Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK Opioids Drug Sales Growth Rate (2013-2018)
Figure GSK Opioids Drug Sales Market Share in United States (2013-2018)
Figure GSK Opioids Drug Revenue Market Share in United States (2013-2018)
Table Grunenthal Basic Information List
Table Grunenthal Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grunenthal Opioids Drug Sales Growth Rate (2013-2018)
Figure Grunenthal Opioids Drug Sales Market Share in United States (2013-2018)
Figure Grunenthal Opioids Drug Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Opioids Drug Sales Growth Rate (2013-2018)
Figure Bayer Opioids Drug Sales Market Share in United States (2013-2018)
Figure Bayer Opioids Drug Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Opioids Drug Sales Growth Rate (2013-2018)
Figure Sanofi Opioids Drug Sales Market Share in United States (2013-2018)
Figure Sanofi Opioids Drug Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Opioids Drug Sales Growth Rate (2013-2018)
Figure Eli Lilly Opioids Drug Sales Market Share in United States (2013-2018)
Figure Eli Lilly Opioids Drug Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Opioids Drug Sales Growth Rate (2013-2018)
Figure AstraZeneca Opioids Drug Sales Market Share in United States (2013-2018)
Figure AstraZeneca Opioids Drug Revenue Market Share in United States (2013-2018)
Table Endo Basic Information List
Table Endo Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Endo Opioids Drug Sales Growth Rate (2013-2018)
Figure Endo Opioids Drug Sales Market Share in United States (2013-2018)
Figure Endo Opioids Drug Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Opioids Drug Sales Growth Rate (2013-2018)
Figure Merck Opioids Drug Sales Market Share in United States (2013-2018)
Figure Merck Opioids Drug Revenue Market Share in United States (2013-2018)
Table Depomed Basic Information List
Table Depomed Opioids Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Depomed Opioids Drug Sales Growth Rate (2013-2018)
Figure Depomed Opioids Drug Sales Market Share in United States (2013-2018)
Figure Depomed Opioids Drug Revenue Market Share in United States (2013-2018)
Table Yunnan Baiyao Basic Information List
Table Teva Basic Information List
Table J&J Basic Information List
Table Allergan Basic Information List
Table Purdue Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioids Drug
Figure Manufacturing Process Analysis of Opioids Drug
Figure Opioids Drug Industrial Chain Analysis
Table Raw Materials Sources of Opioids Drug Major Players/Suppliers in 2017
Table Major Buyers of Opioids Drug
Table Distributors/Traders List
Figure United States Opioids Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Opioids Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Opioids Drug Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Opioids Drug Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Opioids Drug Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Opioids Drug Sales Volume (K Units) Forecast by Type in 2025
Table United States Opioids Drug Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Opioids Drug Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Opioids Drug Sales Volume (K Units) Forecast by Application in 2025
Table United States Opioids Drug Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Opioids Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Opioids Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Opioids Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Opioids Drug Market Report 2018

More Publications

Need Help?

Ask a Question

Market Reports